1. Home
  2. CSBR

as 12-20-2024 3:34pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Founded: 1985 Country:
United States
United States
Employees: N/A City: BALTIMORE
Market Cap: 98.1M IPO Year: 1986
Target Price: $8.00 AVG Volume (30 days): 61.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.04 EPS Growth: N/A
52 Week Low/High: $3.60 - $7.85 Next Earning Date: 12-11-2024
Revenue: $53,571,000 Revenue Growth: 7.19%
Revenue Growth (this year): 14.19% Revenue Growth (next year): 10.11%

CSBR Daily Stock ML Predictions

Share on Social Networks: